New, portable system can be configured to produce different drugs.
MIT researchers have developed a compact, portable pharmaceutical manufacturing system that can be reconfigured to produce a variety of drugs on demand.
Just as an emergency generator supplies electricity to handle a power outage, this system could be rapidly deployed to produce drugs needed to handle an unexpected disease outbreak, or to prevent a drug shortage caused by a manufacturing plant shutdown, the researchers say.
“Think of this as the emergency backup for pharmaceutical manufacturing,” says Allan Myerson, an MIT professor of the practice in the Department of Chemical Engineering. “The purpose is not to replace traditional manufacturing; it’s to provide an alternative for these special situations.”
Such a system could also be used to produce small quantities of drugs needed for clinical trials or to treat rare diseases, says Klavs Jensen, the Warren K. Lewis Professor of Chemical Engineering at MIT.
“The goal of this project was to build a small-scale, portable unit that was completely integrated, so you could imagine being able to ship it anywhere. And as long as you had the right chemicals, you could make pharmaceuticals,” Jensen says.
Jensen, Myerson, and Timothy Jamison, the head of MIT’s Department of Chemistry, are the senior authors of a paper describing the new system in the March 31 online edition of Science. The lead author is MIT research associate Andrea Adamo.
Traditional drug manufacturing, also known as “batch processing,” can take weeks or months. Active pharmaceutical ingredients are synthesized in chemical manufacturing plants and then shipped to other sites to be converted into a form that can be given to patients, such as tablets, drug solutions, or suspensions. This system offers little flexibility to respond to surges in demand and is susceptible to severe disruption if one of the plants has to shut down.
Many pharmaceutical companies are now looking into developing an alternative approach known as flow processing — a continuous process that is done all in one location. Five years ago, an MIT team that included Jamison, Jensen, and Myerson demonstrated a larger prototype (24 by 8 by 8 feet) for the continuous integrated manufacturing of drugs from chemical synthesis to tablets. That project has ended, but the continuous manufacturing initiative, funded by Novartis, is still underway as the researchers develop new methods for synthesis, purification, and formulation.
In the new endeavor, funded by the Defense Advanced Research Projects Agency (DARPA), the MIT researchers built on what they learned from the Novartis-funded project to create a much smaller, transportable device. Their new system can produce four drugs formulated as solutions or suspensions — Benadryl, lidocaine, Valium, and Prozac. Using this apparatus, the researchers can manufacture about 1,000 doses of a given drug in 24 hours.
Key to the continuous system is the development of chemical reactions that can take place as the reactants flow through relatively small tubes as opposed to the huge vats in which most pharmaceutical reactions now take place. Traditional batch processing is limited by the difficulty of cooling these vats, but the flow system allows reactions that produce a great deal of heat to be run safely.
“In many cases we were developing syntheses of targets that had never been done in a continuous flow platform,” Jamison says. “That presents a lot of challenges even if there is a good precedent from the batch perspective. We also recognized it as an opportunity where, because of some of the phenomena that one can leverage in [a flow-based system], you can make molecules differently.”
The chemical reactions required to synthesize each drug take place in the first of two modules. The reactions were designed so that they can take place at temperatures up to 250 degrees Celsius and pressures up to 17 atmospheres.
By swapping in different module components, the researchers can easily reconfigure the system to produce different drugs. “Within a few hours we could change from one compound to the other,” Jensen says.
In the second module, the crude drug solution is purified by crystallization, filtered, and dried to remove solvent, then dissolved or suspended in water as the final dosage form. The researchers also incorporated an ultrasound monitoring system that ensures the formulated drug solution is at the correct concentration.
John Lewin, the division director of critical care and surgery pharmacy at Johns Hopkins Hospital, says this type of manufacturing could bring down production costs and help patients get better access to the drugs they need.
“This sets the foundation for a new paradigm in terms of the way we manufacture pharmaceuticals and distribute them to patients,” says Lewin, who was not involved in the study. “Such a device could really meet a lot of the supply chain challenges here in the U.S. and around the world.”
One of the advantages of this small-scale system is that it could be used to make small amounts of drugs that would be prohibitively expensive to make in a large-scale plant. This would be useful for so-called “orphan drugs” — drugs needed by a small number of patients. “Sometimes it’s very difficult to get those drugs, because economically it makes no sense to have a huge production operation for those,” Jensen says.
It could also be useful in regions with few pharmaceutical storage facilities, because drugs can be produced on demand, eliminating the need for long-term storage.
“The idea here is you make what you need, and you make a simple dosage form, because they’re going to be taken on demand. The dosages don’t have to have long-term stability,” Myerson says. “People line up, you make it, and they take it.”
The researchers are now working on the second phase of the project, which includes making the system about 40 percent smaller and producing drugs whose chemical syntheses are more complex. They are also working on producing tablets, which are more complicated to manufacture than liquid drugs.
Learn more: Pharmacy on demand
The Latest on: Pharmacy on demand
via Google News
The Latest on: Pharmacy on demand
- CVS lifts forecast after strong quarter on insurance demand, COVID testson August 3, 2022 at 3:50 am
CVS Health Corp on Wednesday raised its full-year profit forecast after strength in its insurance business and sales of COVID-19 over-the-counter test kits helped the company report a 6% jump in ...
- Compounding Pharmacy Market Analysis 2022: Topical Medications, Oral Medications, Suppositories - Global Forecast to 2029 - ResearchAndMarkets.comon July 29, 2022 at 7:23 am
The “Compounding Pharmacy Market Analysis by Product (Topical Medications, Oral Medications, Suppositories), by Therapeutic Area (Hormone Replacement Medications, Pain Medications, Dermatological ...
- Local Opinion: FTC is right to investigate pharmacy benefit managerson July 29, 2022 at 6:00 am
In early June, the FTC announced that they would launch investigations into major pharmacy benefit managers and their business practices. This has been a long time coming, as Congress has repeatedly ...
- University Health to add pediatric pharmacy to new women’s and children’s hospitalon July 27, 2022 at 2:19 pm
Use Next and Previous buttons to navigate University Health’s board of managers has approved budget adjustments to facilitate building a pediatric pharmacy inside the county’s under-construction women ...
- Pharmacy Market Size 2022 In-Depth Players Analysis, Future Investments, Supply Demand Scenario, Regional Forecast till 2030on July 27, 2022 at 1:56 am
Global Pharmacy Market is valued approximately USD $billion in 2021 and is anticipated to grow with a healthy growth rate of more than % over the forecast period 2022-2028. Download Free Sample of ...
- Good Neighbor Pharmacy Celebrates 40 Years of Elevating Independent Community Pharmacy at ThoughtSpot 2022on July 22, 2022 at 8:30 am
Good Neighbor Pharmacy & the AmerisourceBergen Foundation announce new scholarship program; The 2022 Pharmacy of the Year Award was presented to Gateway Pharmacy from Phoenixville ...
- Alto Pharmacy Raises $200 Million to Disrupt Retail Pharmacy Marketon July 20, 2022 at 2:30 pm
Healthtech startup Alto Pharmacy announced in January it raised $200 million in a Series E round led by Softbank Vision Fund. Alto operates a digital pharmacy that offers services from hand-delivering ...
- Digital Pharmacy Market | Rise of E-Pharmacy Booming the Pharma Sector - MDC Detailed Analysis Reporton July 20, 2022 at 7:45 am
Technology Assessment (Developments & Economic Impact), Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional FootPrint by MDC ResearchPune, (GLOBE ...
- Valor Compounding Pharmacy Expansion to Support Growing Demandon July 7, 2022 at 12:06 pm
Valor Compounding Pharmacy underwent a major renovation, adding more space to its laboratories and offices to support growing customer demand Valor Compounding Pharmacy has recently added 1,300 ...
- Valor Compounding Pharmacy Expansion to Support Growing Demandon July 7, 2022 at 11:26 am
Valor Compounding Pharmacy underwent a major renovation, adding more space to its laboratories and offices to support growing customer demand BERKELEY, Calif., July 07, 2022--(BUSINESS WIRE ...
via Bing News